- Home
- EZGO vs ESLA Comparison
EZGO vs ESLA Comparison
Compare EZGO & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EZGO | ESLA |
|---|---|---|
| Founded | 2014 | 2021 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Motor Vehicles | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.4M | 30.7M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | EZGO | ESLA |
|---|---|---|
| Price | $0.90 | $0.70 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | ★ 98.3K | 35.4K |
| Earning Date | 07-01-2025 | 05-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.01 | $0.69 |
| 52 Week High | $3.30 | $3.15 |
Technical Indicators
Market Signals| Indicator | EZGO | ESLA |
|---|---|---|
| Relative Strength Index (RSI) | 36.58 | 37.43 |
| Support Level | $0.88 | $0.73 |
| Resistance Level | $1.34 | $1.35 |
| Average True Range (ATR) | 0.10 | 0.07 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 5.66 | 23.56 |
Price Performance
Historical ComparisonAbout EZGO EZGO Technologies Ltd.
EZGO Technologies Ltd is engaged in the sale of e-bicycles and battery and e-bicycle rentals, complemented by the sale of battery packs, battery cell trading and charging pile business. Its product categories include e-bicycle, Intelligent unmanned patrol car, e-motorcycle and e-moped and urban style e-tricycle. Its segments include the Battery cells and packs, electronic control system and intelligent robot segment. and the E-bicycle sales segment. The company generates maximum revenue from the Battery cells and packs segment.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.